STAR mutations causing non‑classical lipoid adrenal hyperplasia manifested as familial glucocorticoid deficiency

Luo,Yuanyuan; Bai,Ruojing; Wang,Zhifang; Zhu,Xiaofan; Xing,Jingjing; Li,Xialian

doi:10.3892/mmr.2020.11140

STAR mutations causing non‑classical lipoid adrenal hyperplasia manifested as familial glucocorticoid deficiency

Authors:
- Yuanyuan Luo
- Ruojing Bai
- Zhifang Wang
- Xiaofan Zhu
- Jingjing Xing
- Xialian Li
View Affiliations

Affiliations: Department of Geriatrics, The First People's Hospital of Yunnan Province, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, Yunnan 650032, P.R. China, Department of Medical Technology, Beijing Health Vocational College, Beijing 100053, P.R. China, Department of Endocrinology and Metabolism, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of Genetic and Prenatal Diagnosis Center, Chinese University of Hong Kong, Hong Kong 999077, SAR, P.R. China
Published online on: May 7, 2020 https://doi.org/10.3892/mmr.2020.11140
Pages: 681-686
Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Familial glucocorticoid deficiency (FGD) is a rare autosomal recessive disease characterized by single cortisol deficiency but normal aldosterone and renin levels. Beginning from the discovery of the disease to that of the pathogenic genes over a period of 30 years, the development of gene detection technology has identified a large number of FGD‑related genes. Despite the fact that the genetic defect underlying this disease is known for approximately 70% of the patients diagnosed with FGD, there are still several unknown factors causing it. FGD is divided into type 1, type 2 and non‑classical type according to the mutant gene. The case described in the present study reported two patients, who were siblings, having skin hyperpigmentation and undergone treatment in adulthood. The gonadal development was normal and the proband had a 10‑year‑old son. Laboratory tests suggested glucocorticoid deficiency and a mild lack of mineralocorticoid, indicating hyponatremia and hypotension in the proband. In addition, cortisol deficiency was not affected by adrenocorticotropic hormone treatment, while the adrenal glands in the two patients did not show any hyperplasia. Gene analysis revealed two compound heterozygote mutations c.533T>A (p. Leu178Gln) and c.737A>G (p. Asp246Gly) in the steroid hormone acute regulatory protein (STAR) gene in both patients, which may have been obtained from their parents and the proband passed one of the mutations to her son. The present study results revealed that STAR mutations cause non‑classic congenital lipoid adrenal hyperplasia in China.

View Figures

View References

1	Shepard TH, Landing BH and Mason DG: Familial Addison's disease; case reports of two sisters with corticoid deficiency unassociated with hypoaldosteronism. AMA J Dis Child. 97:154–162. 1959. View Article : Google Scholar : PubMed/NCBI
2	Clark AJ, McLoughlin L and Grossman A: Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet. 341:461–462. 1993. View Article : Google Scholar : PubMed/NCBI
3	Metherell LA, Chapple JP, Cooray S, David A, Becker C, Rüschendorf F, Naville D, Begeot M, Khoo B, Nürnberg P, et al: Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2. Nat Genet. 37:166–170. 2005. View Article : Google Scholar : PubMed/NCBI
4	Meimaridou E, Kowalczyk J, Guasti L, Hughes CR, Wagner F, Frommolt P, Nürnberg P, Mann NP, Banerjee R, Saka HN, et al: Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency. Nat Genet. 44:740–742. 2012. View Article : Google Scholar : PubMed/NCBI
5	Hughes CR, Guasti L, Meimaridou E, Chuang CH, Schimenti JC, King PJ, Costigan C, Clark AJ and Metherell LA: MCM4 mutation causes adrenal failure, short stature and natural killer cell deficiency in humans. J Clin Invest. 122:814–820. 2012. View Article : Google Scholar : PubMed/NCBI
6	Prasad R, Chan LF, Hughes CR, Kaski JP, Kowalczyk JC, Savage MO, Peters CJ, Nathwani N, Clark AJ, Storr HL and Metherell LA: Thioredoxin Reductase 2 (TXNRD2) mutation associated with familial glucocorticoid deficiency (FGD). J Clin Endocrinol Metab. 99:E1556–E1563. 2014. View Article : Google Scholar : PubMed/NCBI
7	Metherell LA, Naville D, Halaby G, Begeot M, Huebner A, Nürnberg G, Nürnberg P, Green J, Tomlinson JW, Krone NP, et al: Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency. J Clin Endocrinol Metab. 94:3865–3871. 2009. View Article : Google Scholar : PubMed/NCBI
8	Flück CE, Tajima T, Pandey AV, Arlt W, Okuhara K, Verge CF, Jabs EW, Mendonça BB, Fujieda K and Miller WL: Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome. Nat Genet. 36:228–230. 2004. View Article : Google Scholar : PubMed/NCBI
9	Bose HS, Pescovitz OH and Miller WL: Spontaneous feminization in a 46, XX female patient with congenital lipoid adrenal hyperplasia due to a homozygous frameshift mutation in the steroidogenic acute regulatory protein. J Clin Endocrinol Metab. 82:1511–1515. 1997. View Article : Google Scholar : PubMed/NCBI
10	Fujieda K, Tajima T, Nakae J, Sageshima S, Tachibana K, Suwa S, Sugawara T and Strauss JF III: Spontaneous puberty in 46,XX subjects with congenital lipoid adrenal hyperplasia. Ovarian steroidogenesis is spared to some extent despite inactivating mutations in the steroidogenic acute regulatory protein (StAR) gene. J Clin Invest. 99:1265–1271. 1997. View Article : Google Scholar : PubMed/NCBI
11	Clark BJ, Wells J, King SR and Stocco DM: The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem. 269:28314–28322. 1994.PubMed/NCBI
12	King SR, Ronen-Fuhrmann T, Timberg R, Clark BJ, Orly J and Stocco DM: Steroid production after in vitro transcription, translation, and mitochondrial processing of protein products of complementary deoxyribonucleic acid for steroidogenic acute regulatory protein. Endocrinology. 136:5165–5176. 1995. View Article : Google Scholar : PubMed/NCBI
13	Tsujishita Y and Hurley JH: Structure and lipid transport mechanism of a StAR-related domain. Nat Struct Biol. 7:408–414. 2000. View Article : Google Scholar : PubMed/NCBI
14	Stocco DM and Clark BJ: Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev. 17:221–244. 1996. View Article : Google Scholar : PubMed/NCBI
15	Bhangoo A, Anhalt H, Ten S and King SR: Phenotypic variations in lipoid congenital adrenal hyperplasia. Pediatr Endocrinol Rev. 3:258–271. 2006.PubMed/NCBI
16	Baker BY, Lin L, Kim CJ, Raza J, Smith CP, Miller WL and Achermann JC: Nonclassic congenital lipoid adrenal hyperplasia: A new disorder of the steroidogenic acute regulatory protein with very late presentation and normal male genitalia. J Clin Endocrinol Metab. 91:4781–4785. 2006. View Article : Google Scholar : PubMed/NCBI
17	Flück CE, Pandey AV, Dick B, Camats N, Fernández-Cancio M, Clemente M, Gussinyé M, Carrascosa A, Mullis PE and Audi L: Characterization of novel StAR (steroidogenic acute regulatory protein) mutations causing non-classic lipoid adrenal hyperplasia. PLoS One. 6:e201782011. View Article : Google Scholar : PubMed/NCBI
18	Miller WL: Mitochondrial specificity of the early steps in steroidogenesis. J Steroid Biochem Mol Biol. 55:607–616. 1995. View Article : Google Scholar : PubMed/NCBI